Hormone Panel — TRT & HGH Intake

Comprehensive hormone evaluation required before starting any therapy programme at Advanced TRT Clinic San Francisco. The panel covers testosterone (total and free), IGF-1 as the primary growth hormone activity marker, a full pituitary hormone screen, thyroid function (TSH, T3, T4), fasting glucose and HbA1c for metabolic health, and a cardiovascular lipid profile. Results are reviewed by a specialist who designs a personalised protocol matched to your hormone profile and health goals.

Advanced TRT Clinic San Francisco conducts a thorough hormone panel assessment before initiating testosterone replacement therapy (TRT), HGH therapy, or any peptide protocol. The diagnostic workup gives prescribing physicians a complete picture of endocrine function, metabolic health, and cardiovascular risk — ensuring every treatment plan is precisely dosed and clinically safe from the outset. The intake panel includes testosterone (total and free), luteinising hormone (LH), follicle-stimulating hormone (FSH), and prolactin as part of the pituitary hormone screen, establishing the root cause of low testosterone rather than treating the symptom in isolation. IGF-1 is the primary marker assessed when HGH therapy is being considered, as it reflects downstream growth hormone activity in peripheral tissue. Thyroid function — TSH, free T3, and free T4 — is included because hypothyroidism commonly mimics and compounds low-testosterone symptoms such as fatigue, weight gain, and reduced libido. Metabolic health markers (fasting glucose and HbA1c) are tested because testosterone therapy can affect insulin sensitivity, and a baseline is essential for safe long-term management. The lipid panel (total cholesterol, LDL, HDL, triglycerides) provides a cardiovascular baseline before beginning therapy that may influence lipid metabolism. Once therapy begins, follow-up blood panels are conducted at regular intervals — typically at 6 weeks and 3 months initially — to confirm that hormone levels have reached the therapeutic range and that haematocrit, PSA, and liver enzymes remain within safe limits. This ongoing lab-monitoring model is central to the Advanced TRT Clinic approach, distinguishing it from clinics that prescribe without structured follow-up. Patients across the San Francisco Bay Area, including those commuting from Oakland, Berkeley, Emeryville, and Daly City, access the Financial District suite for both initial consultations and results reviews.